Search

everythinglearnresearchcommunity

for

Search:↓

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Sry may regulate fatty acid metabolism and shows different expression levels in rat tissues.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

AB+ blood group is more common in alopecia areata patients.

No link found between hair loss severity and PSA levels in men.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

Higher antigliadin antibody levels are linked to alopecia areata severity.

IsoPSA test works accurately even if patients take certain prostate medications.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

rwSALT provides precise hair regrowth measurement from scalp photos.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Certain gene variations increase the risk of alopecia areata in Koreans.

Alcohol dependence affects stress hormone levels more than childhood maltreatment.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

People with alopecia areata often have abnormal thyroid hormones, thyroid antibodies, antinuclear antibodies, low vitamin D, and high C-reactive protein levels.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Two methods reliably measure scalp area and hair count.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

A lower second to fourth finger length ratio may predict male alopecia areata.

Certain blood markers, especially MLR, can help diagnose alopecia areata.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.